ESMO - Eur. Oncology· @myESMO · X·· 19 小时前评分70
正文 · 原文
Today is the day at #ESMO26!
@ProfGLongMIA will present the full results of INTerpath-001, followed by an expert, contextualised interpretation of the data by Inge Marie Svane.
Don't miss Presidential Symposium I
⏰16:30 - 18:15
📍Alicante Auditorium - Hall 6
60 浏览 · 0 赞 · 0 转发 · 0 回复
会议摘要
LBA1按 Presidential Symposium I 对上
INTerpath-001: Phase 3 study of the mRNA-based individualized neoantigen therapy (INT) intismeran autogene (intismeran) plus pembrolizumab (pembro) vs pembro alone for adjuvant treatment of resected stage IIB-IV melanoma (MEL)
https://esmocongress.esmo.orgINTerpath-001
https://esmocongress.esmo.orgAhead of #ESMO26, #CancerVaccines are generating global attention, but what questions still need answering before they can reshape #ClinicalPractice? Read more in an interview with James Larkin, ESMO Congress 2026 Scientific Co-Chair 🔗 https://ow.ly/Hzug50ZXEg9 #InsightsbyESMO在 X 查看被引用的帖子
来源：ESMO - Eur. Oncology · x.com